Information  X 
Enter a valid email address

Deutsche Bank AG (0H7D)

  Print          Annual reports

Thursday 12 August, 2021

Deutsche Bank AG

Form 38.5a (EPT/RI) - UDG Healthcare plc

RNS Number : 4623I
Deutsche Bank AG
12 August 2021
 

Ap24

 

FORM   38.5(a)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND 

DEALING IN A CLIENT-SERVING CAPACITY

 

1.  KEY   INFORMATION

 

Nameofexemptprincipaltrader

 Deutsche Bank AG London

Companydealtin

 UDG Healthcare plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 1)

 Ordinary Shares

Date of dealing

 11/08/2021

 

2.  DEALINGS  (Note   2)

 

(a)  Purchases and sales

 

Total numberofrelevantsecuritiesacquired

Highestpricepaid (Note 3)

Lowest price paid

(Note 3)

 4,394

10.7900 GBP

10.7900 GBP

 

Total numberofsecuritiesdisposed

Highestpricereceived (Note 3)

Lowestpricereceived

(Note 3)

 4,394

10.7884 GBP

10.7884 GBP

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 4)

Numberofrelevantsecurities

(Note 5)

Priceperunit

(Note 3)

 

 

 

 

 

 

Ap25

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing,   selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varyingetc.

Number of securities to which the option relates (Note 5)

Exercise price

Type, e.g. American, Europeanetc.

Expiry date

Option money paid/received perunit (Note 3)

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 3)

 

 

 

 

3.   OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the  voting   rights   of   any   relevant   securities   under   any   option   referred

  to   on   this   form   or   relating   to   the   voting   rights  or future acquisition or disposal of any relevant securities to 

which any derivative referred to on this form is referenced. If none, this should be stated. 

 

  None

 

 

 

 

Dateofdisclosure

12/08/2021

Contactname

Gurpreet Kaur Kang

Telephone number

+44 121 407 8493

Name of offeree/offeror with which connected

 Nenelite Limited

Nature of connection (Note 6)

 Financial Adviser and Corporate Broker

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEGZGMRGZNGMZM

a d v e r t i s e m e n t